New Trends in Anticoagulation Therapy.

about

New Trends in Anticoagulation Therapy.

Item

http://www.wikidata.org/entity/Q52675244

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

New Trends in Anticoagulation Therapy.

@en

New Trends in Anticoagulation Therapy.

@nl

type

Item

label

New Trends in Anticoagulation Therapy.

@en

New Trends in Anticoagulation Therapy.

@nl

prefLabel

New Trends in Anticoagulation Therapy.

@en

New Trends in Anticoagulation Therapy.

@nl

P1476

New Trends in Anticoagulation Therapy.

@en

P2093

Andrea Obi

http://www.w3.org/2001/XMLSchema#string

Glenn Wakam

http://www.w3.org/2001/XMLSchema#string

Margaret Smith

http://www.w3.org/2001/XMLSchema#string

Thomas Wakefield

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Idarucizumab for Dabigatran Reversal

Oral rivaroxaban for symptomatic venous thromboembolism

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.

P304

219-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SUC.2017.11.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29502768

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5973805

http://www.w3.org/2001/XMLSchema#string